Back to Search
CHRISTOPHER MESA, M.D.
M.D.
Rheumatology Physician
NPI: 1598150542IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
ME149611(FL)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 2013
Research & Publications (20)
Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles.
PMID 19368771·Vaccine·2009
7-preclinical
Internally controlled triplex quantitative PCR assay for human polyomaviruses JC and BK.
PMID 18614652·J Clin Microbiol·2008
8-other
Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.
PMID 18351335·Cancer Immunol Immunother·2008
7-preclinical
Differential influence of the tumour-specific non-human sialic acid containing GM3 ganglioside on CD4+CD25- effector and naturally occurring CD4+CD25+ regulatory T cells function.
PMID 18310617·Int Immunol·2008
7-preclinical
Dynamics of DNA adsorption on and release from SDS-DDAB cat-anionic vesicles: a multitechnique study.
PMID 18220427·Langmuir·2008
8-other
Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
PMID 18167135·Clin Endocrinol (Oxf)·2008
8-other
Optimization of 6-carboxy-X-rhodamine concentration for real-time polymerase chain reaction using molecular beacon chemistry.
PMID 17538648·Can J Microbiol·2007
8-other
Some properties of lysozyme--lithium perfluorononanoate complexes.
PMID 17291063·Biomacromolecules·2007
8-other
Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells.
PMID 16208470·Cancer Immunol Immunother·2006
7-preclinical
Angiotensin-converting enzyme I/D polymorphism and preeclampsia risk: evidence of small-study bias.
PMID 17194198·PLoS Med·2006
1-meta
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.
PMID 17145833·Clin Cancer Res·2006
7-preclinical
Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for dendritic cell activation.
PMID 16823920·Vaccine·2006
7-preclinical
Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.
PMID 16818623·Cancer Res·2006
7-preclinical
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens.
PMID 16316710·Vaccine·2006
7-preclinical
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
PMID 16254036·Endocrinology·2006
7-preclinical
Making polysomnography more "child friendly:" a family-centered care approach.
PMID 17561635·J Clin Sleep Med·2005
8-other
Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors.
PMID 16112257·Vaccine·2005
7-preclinical
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
PMID 15781663·Cancer Res·2005
7-preclinical
Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine.
PMID 15713700·J Clin Endocrinol Metab·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2510 SW 27TH AVE STE 101
MIAMI, FL 33133 - Phone
- (786) 703-7000
Quick Facts
- NPI
- 1598150542
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile